6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: China SXT Pharmaceuticals, Inc.
Filed: February 3, 2021
Period of Report: February 3, 2021
Accession Number: 0001213900-21-006350

View Document ↗ View on SEC.gov ↗